Molecular and behavioral studies have identified heterodimers of the T1R family as receptors for detecting the tastes of sweet (T1R2 + T1R3) and umami (T1R1 + T1R3). However, behavioral studies have reported conflicting findings with T1R3 knockout (KO) mice. One study showed a complete or nearly complete loss of preference for sweet and umami substances by KO mice, whereas KO mice in another study showed only a partial reduction in preferences for sucrose and monosodium glutamate (MSG), the prototypical umami substance. The present experiments used psychophysical methods to assess how sensitive T1R1-KO mice are to sucrose and MSG and discrimination methods to determine if these mice could distinguish between the tastes of sucrose and MSG. Detection thresholds of T1R3-KO mice and wild-type (WT) C57Bl mice were nearly identical for sucrose and MSG. Mice of both genotypes were easily able to discriminate between the tastes of sucrose and MSG. When amiloride (a sodium channel blocker) was added to all solutions to reduce the taste of Na+, discrimination accuracy of both genotypes of mice decreased but more so for the T1R3-KO mice than the WT mice. However, even when the sodium taste of MSG was neutralized, both genotypes could still discriminate between the two substances well above chance performance. These results suggest that sucrose and MSG can be detected by taste receptors other than T1R2 + T1R3 and T1R1 + T1R3 and that the conflicts between the previous studies may have been due to the methodological limitations.

Females are more affected by psychiatric illnesses including eating disorders, depression, and post-traumatic stress disorder than males. However, the neural mechanisms mediating these sex differences are poorly understood. Animal models can be useful in exploring such neural mechanisms. Conditioned taste aversion (CTA) is a behavioral task that assesses how animals process the competition between associated reinforcing and aversive stimuli in subsequent task performance, a process critical to healthy behavior in many domains. The purpose of the present study was to identify sex differences in this behavior and associated neural responses. We hypothesized that females would value the rewarding stimulus (Boost®) relative to the aversive stimulus (LiCl) more than males in performing CTA. We evaluated behavior (Boost® intake, LiCl-induced behaviors, ultrasonic vocalizations (USVs), CTA performance) and Fos activation in relevant brain regions after the acute stimuli [acute Boost® (AB), acute LiCl (AL)] and the context-only task control (COT), Boost® only task (BOT) and Boost®-LiCl task (BLT). Acutely, females drank more Boost® than males but showed similar aversive behaviors after LiCl. Females and males performed CTA similarly. Both sexes produced 55 kHz USVs anticipating BOT and inhibited these calls in the BLT. However, more females emitted both 22 kHz and 55 kHz USVs in the BLT than males: the latter correlated with less CTA. Estrous cycle stage also influenced 55 kHz USVs. Fos responses were similar in males and females after AB or AL. Females engaged the gustatory cortex and ventral tegmental area (VTA) more than males during the BOT and males engaged the amygdala more than females in both the BOT and BLT. Network analysis of correlated Fos responses across brain regions identified two unique networks characterizing the BOT and BLT, in both of which the VTA played a central role. In situ hybridization with RNAscope identified a population of D1-receptor expressing cells in the CeA that responded to Boost® and D2 receptor-expressing cells that responded to LiCl. The present study suggests that males and females differentially process the affective valence of a stimulus to produce the same goal-directed behavior.

Twenty-five to fifty percent of patients undergoing chemotherapy will develop anticipatory nausea and vomiting (ANV), in which symptoms occur in anticipation of treatment. ANV is triggered by environmental cues and shows little response to traditional antiemetic therapy, suggesting that unique neural pathways mediate this response. Understanding the underlying neural mechanisms of this disorder is critical to the development of novel therapeutic interventions. The purpose of the present study was to identify brain areas activated during ANV and characterize sex differences in both the behavior and the brain areas activated during ANV. We used a rat model of ANV by pairing a novel context with the emetic drug lithium chloride (LiCl) to produce conditioned nausea behaviors in the LiCl-paired environment. We quantitated gaping, an analog of human vomiting, after acute or repeated LiCl in a unique environment. To identify brain regions associated with gaping, we measured c-fos activation by immunochemical staining after these same treatments. We found that acute LiCl activated multiple brain regions including the supraoptic nucleus of the hypothalamus, central nucleus of the amygdala, nucleus of the solitary tract and area postrema, none of which were activated during ANV. ANV activated c-fos expression in the frontal cortex, insula and paraventricular nucleus of the hypothalamus of males but not females. These data suggest that therapies such as ondansetron which target the area postrema are not effective in ANV because it is not activated during the ANV response. Further studies aimed at characterizing the neural circuits and cell types that are activated in the conditioned nausea response will help identify novel therapeutic targets for the treatment of this condition, improving both quality of life and outcomes for patients undergoing chemotherapy.

This study evaluated behavior (Boost® intake, LiCl-induced behaviors, ultrasonic vocalizations (USVs), task performance) and c-fos activation during conditioned taste aversion (CTA) to understand how males and female rats assess the relative danger or safety of a stimulus in learning and performing a task. Females drank more Boost® than males but engaged in comparable aversive behaviors after LiCl treatment. Males produced 55 kHz USVs (indicating positive valence), when anticipating Boost® and inhibited these calls after pairing with LiCl. Females produced 55 kHz USVs based on their estrous cycle but were more likely to make 22 kHz USVs than males (indicating negative valence) after pairing with LiCl. C-fos responses were similar in males and females after Boost® or LiCl. Females engaged the gustatory cortex more than males during the reinforcing task and males engaged the amygdala more than females in both the reinforcing and devalued tasks. RNAscope identified a population of D1-receptor expressing cells in the CeA that responded to Boost® and D2 receptor-expressing cells that responded to LiCl. The present study suggests that males and females differentially process the affective valence of a stimulus to produce the same goal-directed behavior.

No abstract